The anti-apoptotic MAP kinase pathway is inhibited in NIH3T3 fibroblasts with increased expression of phosphatidylinositol transfer protein β  by Schenning, Martijn et al.
Available online at www.sciencedirect.com
1773 (2007) 1664–1671
www.elsevier.com/locate/bbamcrBiochimica et Biophysica ActaThe anti-apoptotic MAP kinase pathway is inhibited in NIH3T3 fibroblasts
with increased expression of phosphatidylinositol transfer protein β
Martijn Schenning ⁎, Claudia M. van Tiel, Karel W.A. Wirtz, Gerry T. Snoek
Bijvoet Center, Department of Biochemistry of Lipids, Institute of Biomembranes, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands
Received 20 March 2007; received in revised form 18 June 2007; accepted 19 June 2007
Available online 26 June 2007Abstract
Mouse NIH3T3 fibroblast cells overexpressing phosphatidylinositol transfer protein β (PI-TPβ, SPIβ cells) demonstrate a low rate of
proliferation and a high sensitivity towards UV-induced apoptosis when compared with wtNIH3T3 cells. In contrast, SPIβS262A cells over-
expressing a mutant PI-TPβ that lacks the protein kinase C-dependent phosphorylation site Ser-262, demonstrate a phenotype comparable with
wtNIH3T3 cells. This suggests that the phosphorylation of Ser-262 in PI-TPβ is involved in the regulation of apoptosis. Conditioned medium (CM)
fromwtNIH3T3 cells contains bioactive factors, presumably arachidonic acid metabolites [H. Bunte, et al., 2006; M. Schenning, et al., 2004] that are
able to protect SPIβ cells against UV-induced apoptosis. CM from SPIβ cells lacks this protective activity. However, after heat denaturation CM from
SPIβ cells regains a protective activity comparable with that of wtNIH3T3 cells. This indicates that CM from SPIβ cells contains an antagonistic
factor interfering with the anti-apoptotic activity present. SPIβS262A cells do not produce the antagonist suggesting that phosphorylation of Ser-262
is required. Moreover, in line with the apparent lack of anti-apoptotic activity, CM from SPIβ cells does not induce the expression of COX-2 or the
activation of p42/p44 MAP kinase in SPIβ cells. In contrast, CM from wtNIH3T3 and SPIβS262A cells or heat-treated CM from SPIβ cells does
induce these anti-apoptotic markers. Since we have previously shown that some of the arachidonic acid metabolites present in CM from wtNIH3T3
cells are prostaglandin (PG) E2 and PGF2α, we investigated the effect of these PGs on cell survival. Although PGE2 and PGF2αwere found to protect
wtNIH3T3 and SPIβS262A cells against UV-induced apoptosis, these PGs failed to rescue SPIβ cells. The fact that the concentrations of PGE2 and
PGF2α in the CM from SPIβ cells and wtNIH3T3 cells were found to be comparable suggests that the failure of these PGs to protect SPIβ cells could
render these cells more apoptosis sensitive. Concomitantly, upon incubation with PGE2 and PGF2α, an increased expression of COX-2 and activation
of p42/p44 MAP kinase were observed in wtNIH3T3 and SPIβS262A cells but not in SPIβ cells. Hence, it appears that specific mechanisms of cell
survival are impaired in SPIβ cells.
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The mammalian phosphatidylinositol transfer protein β (PI-
TPβ) is a highly conserved protein with up to 99% sequence
identity between species [1,2]. It shares 77% sequence identity
with its isoform PI-TPα. PI-TPβ is mainly associated with the
Golgi system and may be the functional analogue of Sec14p, the
major yeast PI-TP [3,4]. Although its physiological function has
not yet been established, its importance follows from the obser-
vation that gene ablation of PI-TPβ in murine embryonic stem
cells prevents embryonic development [5]. Murine embryos
lacking PI-TPα develop normally but die within 2 weeks after
birth [6]. This clearly shows that these two isoforms serve
different functions in the cell.
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increase in PI-TPβ levels (SPIβ cells) we observed that these
cells display a decreased growth rate relative to the wtNIH3T3
cells [7]. In addition, under conditions where sphingomyelin
(SM) in the plasma membrane was hydrolyzed to ceramide by
exogenous sphingomyelinase, SPIβ cells in contrast to
wtNIH3T3 cells maintained the steady-state levels of SM in
the plasma membrane suggesting that PI-TPβ was involved in
this process [7]. This is in agreement with the finding that in
vitro PI-TPβ binds and transfers SM in addition to PI and PC
while PI-TPα lacks the ability to transfer SM [8]. Unlike SPIβ
cells, mutant SPIβS262A cells were unable to instantaneously
replenish SM after its degradation by exogenous sphingomye-
linase, strongly suggesting that the phosphorylation of Ser-262
was required [9,10]. If SM replenishment is linked to membrane
vesicle flow it could be that PI-TPβ plays a role in the budding
process, an activity analogous to Sec14p function in yeast [11].
In contrast to SPIβ cells, cells with an increased expression of
PI-TPα (SPIα cells) demonstrate a highly increased rate of
proliferation as well as an increased survival upon induction of
apoptosis [12,13]. Furthermore, it was shown that SPIα cells
produce a PI-TPα/COX-2-dependent mitogenic and anti-apop-
totic factor. Upon secretion, this factor is able to stimulate
growth and to promote survival in wtNIH3T3 and SPIβ cells
[13]. In agreement with the increased resistance of these cells
towards UV-induced apoptosis, the PI-TPα-dependent survival
factor induced COX-2 expression in both cell lines. In addition it
had been reported that this survival factor is able to prevent
apoptosis in rat motor neurons, suggesting a vital role in the
central nervous system [14].
In earlier studies we have shown that SPIβ cells, when
compared with wtNIH3T3 cells, are very susceptible towards
UV-induced apoptosis, whereas the SPIβS262A cells behave
similar to wtNIH3T3 cells [15]. Here we report that two abun-
dant COX-1,-2 dependent arachidonic acid metabolites, PGE2
and PGF2α do not protect SPIβ cells against apoptosis whereas
wtNIH3T3 and SPIβS262A cells are protected. In addition, we
report that conditioned medium (CM) from SPIβ cells contains a
heat-labile antagonist masking the survival factor present. This
antagonist prevents the activation of the anti-apoptotic p42/p44
MAP kinase pathway and the upregulation of COX-2.
2. Materials and methods
2.1. Materials
Prostaglandins PGE2 and PGF2α were obtained from Sigma, polyclonal
antibodies against COX-1/COX-2 from Cayman; anti-p42/p44 MAP kinase
antibodies where obtained from Cell Signaling technology, DMEM and NCS
from Invitrogen; PGE2 ELISA kit was obtained from Cayman.
2.2. Cell culture
All cells were cultured in Dulbecco's modified Eagles medium (DMEM)
containing 10% newborn calf serum (NCS) and buffered with 44 mM NaHCO3.
Cells were maintained at 7.5% CO2 at 37 °C in a humidified atmosphere. Wild
type cells used were designated ATCC CRL 1658 NIH3T3 cells. The SPIα cells
were obtained as described in Snoek et al. [12]. The SPIβ cells and SPIβS262A
cells were obtained as described in van Tiel et al. [7] and van Tiel et al. [9].2.3. Preparation of conditioned medium
Cells were grown to 90% confluency in 150 cm2 dishes. After washing the
cells twice with PBS, the mediumwas replaced with 13 ml of DMEM containing
0.1% bovine serum albumin (DBB medium). After 24 h the medium was
collected and centrifuged (10 min at 1000 rpm) to remove floating cells. The
supernatant is the conditioned medium (CM). Neutral lipids were extracted from
CM with two 39 ml portions of ethyl acetate (after adjusting to pH 2.0 with
formic acid) [16]. CM was heat-denatured by incubation for 20 min at 80 °C,
then centrifuged for 10 min at 17,500×g and the supernatant used for
experiments. Under standard conditions 90% confluent cells were incubated
with CM derived from an identical surface of cells (i.e. 9.5 cm2 of cells per well
of a six-well dish was incubated with the amount of CM or neutral lipid extract
derived from 9.5 cm2 of cells).
2.4. Induction of apoptosis
Induction of apoptosis by serum starvation: Cells were seeded in 6-well
plates and grown under standard conditions for 48 h until ca 85% confluency.
Growth medium was removed and the cells were washed with PBS. The cells
were incubated with DMEM containing 0.1% bovine serum albumin (DBB
medium) for 16 h at 37 °C and the percentage of apoptotic cells was
morphologically determined as the percentage of cells that was in the process of
blebbing.
Induction of apoptosis by tumor necrosis factor α (TNFα): Cells were
seeded in 6-well plates and grown under standard conditions for 48 h until ca
85% confluency. Growth medium was removed and cells were washed with
PBS. The cells were incubated with DBB medium containing cycloheximide
(2.5 μg/ml) and TNFα (10 ng/ml) and the cells were incubated for 7 h at 37 °C
and the percentage of apoptotic cells was morphologically determined as the
percentage of cells that was in the process of blebbing.
Induction of apoptosis by UV irradiation: Cells were seeded in 6-well plates
and grown for 48 h until ca 85% confluency. Growth medium was removed and
cells were washed with PBS. Before UV treatment, the cells were incubated for
4 h in DBB medium. To investigate the effects on the sensitivity to apoptosis,
CM or prostaglandins were added to this DBB during the incubation prior to UV
irradiation. The medium was removed and the cells were given a UV dose
(200 J/m2) using a Stratalinker (Stratagene). After UV irradiation, the cells were
incubated with DBB at 37 °C. At the indicated time points cell death was
morphologically determined as described above.
2.5. Determination of COX-1 and COX-2 levels
Cells were grown in 21 cm2 dishes to 80–90% confluency. Cells were
washed twice with PBS and lysed in 20 mM Tris–HCl pH 7.5 containing
0.1% (v/v) NP40. The cell lysate was centrifuged at 17,500×g for 10 min at
4 °C and the protein content of the supernatant fraction determined using the
Bradford assay [17]. Equal amounts of supernatant proteins (50 μg) were
subjected to SDS-PAGE on a 12% gel and Western blot analysis was
performed using an antibody specific for COX-1 or COX-2. To determine
whether equal amounts of protein were analyzed, blots were stained with
ponceau S and scanned. The levels of COX-1 or -2 on the immunoblot were
quantified using a Bio-Rad GS700 imaging densitometer equipped with an
integrating program. In some experiments prior to harvesting the cells were
incubated with CM for 5 h.
2.6. Determination of p42/44 MAP kinase levels
Cells were grown in 21 cm2 dishes to 80–90%confluency. Cells werewashed
twice with PBS and lysed in 20 mM Tris–HCl pH 7.5 containing 0.1% (v/v)
NP40, 10 mM β-glycerophosphate, 1 mMNa3VO4, 50 mMNaF, 1 mM aprotinin
and 1 mM PMSF. Sample preparation was performed as described above.
Western blot analysis was performed using an antibody specific for p42/44 MAP
kinase and immunoreactive bands were quantified. To determine whether equal
amounts of protein were analyzed, blots were stained with ponceau S and
scanned. In some experiments prior to harvesting the cells were incubated with
CM for 10 min.
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Cells were grown to 80% confluency and total lipids were extracted by the
method of Bligh and Dyer [18]. Ceramide levels were determined using the
Escherichia coli diacylglycerol kinase assay as described [19]. Briefly, the
lipids were incubated at room temperature for 30 min in the presence of β-
octylglucoside/dioleoyl-phosphatidyl glycerol micelles, 2 mM dithiothreitol,
5 μg of proteins from the diacylglycerol kinase membranes, and 2 mM ATP
(mixed with [γ-32P]ATP) in a final volume of 100 μl. After Bligh and Dyer
extraction the lipids were separated by thin layer chromatography (TLC) in
chloroform:acetone:methanol:acetic acid:H2O (50:20:15:10:5, by vol.) and the
radioactivity associated with ceramide-phosphate was measured. Ceramide
levels were quantified using external standards and were normalized to
phosphate. SM levels were determined as described previously [7].
3. Results
3.1. Apoptosis sensitivity of wtNIH3T3, SPIβ and SPIβS262A
cells
Previously we have shown that SPIβ cells are sensitive
towards UV-induced apoptosis [15]. Exposure of theFig. 1. (A) Survival of wtNIH3T3, SPIβ and SPIβS262A cells upon induction of apo
confluency. Serum starvation: growth medium was replaced by DMEM/Bic/0.1% bov
induced apoptosis: growth medium was replaced by DBB containing cycloheximide
UV induced apoptosis: growth medium was replaced by DBB and cells were incubate
fresh DBBwas added to the cells and incubated for 3 h at 37 °C. The number of apopto
mean values of at least three independent experiments. p-values were calculated relati
of blebbing wtNIH3T3, SPIβ and SPIβS262A cells. Cells were grown to 85% conflu
cells were irradiated with 200 J/m2 and fresh DBB was added. Images were taken 90
wtNIH3T3 cells; middle panel, SPIβ cells; right panel, SPIβS262A cells. (C) Long a
grown to 80% confluency and total lipids were extracted by the method of Bligh and
experiments. p-values were calculated relative to the level of long chain SM in wtNwtNIH3T3, SPIβ and SPIβS262A cells to other apoptotic
stimuli (i.e. 10 ng/ml TNFα, 2.5 μg/ml; serum starvation)
showed that the increased apoptotic response of the SPIβ
cells was not restricted to UV irradiation. Under all conditions
tested, SPIβ cells showed a significantly higher extent of
apoptosis than wtNIH3T3 and SPIβS262A cells (Fig. 1A).
This is illustrated by Fig. 1B, which shows the extent of
blebbing 90 min after UV irradiation. These images, at all
time points shown, have been visually analyzed to determine
the extent of apoptosis.
Because SM metabolism may play a role in apoptosis
[20–23] , we analyzed SM and ceramide in SPIβ,
SPIβS262A and wtNIH3T3 cells. In agreement with previous
studies [7], SM levels were comparable in the three cell lines,
(i.e. 59 pmol/nmol of total lipid). Similar to other studies, we
observed that SM separated in two bands by TLC [24,25].
The lower band represents short-chain (C16:0) and the upper
band long-chain (C24:0/1) SM species. However, we noticed
that the relative proportion of the two classes of SM species
was different in the three cell lines (Fig. 1C). Specifically,ptosis by UV irradiation, TNFα or serum deprivation. Cells were grown to 90%
ine serum albumin (DBB) and the cells were incubated for 16 h at 37 °C. TNFα
(2.5 μg/ml) and TNFα (10 ng/ml) and the cells were incubated for 7 h at 37 °C.
d for 4 h at 37 °C. After removal of DBB the cells were irradiated with 200 J/m2,
tic cells (blebbing) was determined by visual analysis. Results±SD represent the
ve to the survival of wtNIH3T3 cells (⁎⁎pb0.01; ⁎⁎⁎pb0.001). (B) Photographs
ency. Cells were incubated for 4 h at 37 °C with DBB. After removal of DBB the
min after UV irradiation on a Nikon TE2000 U inverted microscope. Left panel,
nd short chain SM levels in wtNIH3T3, SPIβ and SPIβS262A cells. Cells were
Dyer [18]. Results±SD represent the mean values of at least three independent
IH3T3 cells (⁎⁎⁎pb0.001).
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chain than long chain SM species (ratio of long chain over short
chain of 0.7), whereas SPIβ cells have relatively less short chain
than long chain SM species (ratio of 1.25). Ceramide analysis of
wtNIH3T3 and SPIβ cells showed that the species composition
was similar to that of SM (data not shown).
In agreement with previous observations PGE2 and PGF2α
are able to protect wtNIH3T3 mouse fibroblast cells against
apoptosis (Fig. 2A) [26,27]. Incubation of SPIβ cells with these
prostaglandins did not protect these cells against UV-induced
apoptosis, whereas CM from wtNIH3T3 cells did protect
(Fig. 2B). The concentration of PGE2 and PGF2α used were
0.5 and 0.1 ng/ml respectively. These concentrations are com-Fig. 2. Survival of wtNIH3T3, SPIβ and SPIβS262A cells upon induction of
apoptosis by UV irradiation. Cells were grown to 90% confluency. The growth
medium was replaced by DMEM/Bic/0.1% bovine serum albumin (DBB), DBB
containing PGE2 (0.5 ng/ml) and PGF2α (0.1 ng/ml) or CM fromwtNIH3T3 cells
and the cells were incubated for 4 h at 37 °C. After removal of DBB or CM, the
cells were irradiated with UV light (200 J/m2). Fresh DBB was added to the cells
and the number of apoptotic cells (blebbing) was determined by visual analysis at
the indicated times. Results±SD represent the mean values of at least three
independent experiments performed in duplicate.
Fig. 3. (A) Expression of COX-2 in wtNIH3T3, SPIβ and SPIβS262A upon
incubation with PGE2/PGF2α or CM from wtNIH3T3 cells. Cells were grown to
90% confluency and incubated with DMEM/Bic/0.1% bovine serum albumin
(DBB), DBB containing PGE2 (0.5 ng/ml) and PGF2α (0.1 ng/ml) or CM from
wtNIH3T3 cells for 5 h at 37 °C. Equal amounts of cell lysate protein (30 μg)
from NIH3T3, SPIβ and SPIβS262A cells were subjected to SDS PAGE
followed by Western blot analysis using a COX-2 specific antibody.
Representative experiment performed in triplicate. p-values were calculated
relative to the COX-2-immunoband obtained from the cells incubated with DBB
(⁎⁎pb0.01; ⁎⁎⁎pb0.001). (B) Phosphorylation of p42/p44 MAP kinase in
wtNIH3T3, SPIβ and SPIβS262A upon incubation with PGE2/PGF2α or CM
from wtNIH3T3 cells. Cells were grown to 90% confluency and incubated with
DMEM/Bic/0.1% bovine serum albumin (DBB), DBB containing PGE2 (0.5 ng/
ml) and PGF2α (0.1 ng/ml) or CM from NIH3T3 cells for 10 min at 37 °C. Equal
amounts of cell lysate protein (25 μg) from NIH3T3, SPIβ and SPIβS262A cells
were subjected to SDS-PAGE followed by Western blot analysis using a p42/
p44 MAP kinase specific antibody. Representative experiment performed in
triplicate. p-values were calculated relative to the p42/p44 MAPK-immuno-
bands obtained from the cells incubated with DBB (⁎pb0.05; ⁎⁎pb0.01;
⁎⁎⁎pb0.001).parable to the levels detected in CM from SPIα cells and are
approximately 5-fold higher compared to the levels detected in
CM from wtNIH3T3 [13] and SPIβ cells. A similar protection
was observed when neutral lipid extracts from this CM were
used (data not shown). Similar to wtNIH3T3, SPIβS262A cells
were protected by both PGE2/PGF2α and CM from wtNIH3T3
cells (Fig. 2A–C).
Fig. 4. Survival of SPIβ cells upon induction of apoptosis by UV irradiation after
preincubation with CM from wtNIH3T3, SPIβ and SPIβS262A cells with or
without heat denaturation. SPIβ cells were grown to 90% confluency. The
growth medium was replaced by DMEM/Bic/0.1% bovine serum albumin
(DBB) or by CM and the cells were incubated for 4 h at 37 °C. After removal of
DBB the cells were irradiated with UV light (200 J/m2), fresh DBB was added to
the cells and incubated for 3 h at 37 °C. The number of apoptotic cells (blebbing)
was determined by visual analysis. Results±SD represent the mean values of at
least three experiments performed in duplicate. p-values were calculated relative
to the survival of SPIβ cells incubated with the untreated conditioned medium
(⁎⁎⁎pb0.001).
Fig. 5. (A) Expression of COX-2 in SPIβ cells upon incubation with CM from
wtNIH3T3, SPIβ and SPIβS262Awith or without heat denaturation of the CM.
Cells were grown to 90% confluency and incubated for 5 h at 37 °C with CM
from NIH3T3, SPIβ or SPIβS262A cells, either heat denatured or not. Equal
amounts of cell lysate protein (30 μg) from NIH3T3, SPIβ and SPIβS262A cells
were subjected to SDS PAGE followed by Western blot analysis using a COX-2
specific antibody. Representative experiment performed in triplicate. p-values
were calculated relative to the COX-2-immunoband obtained from the SPIβ
incubated with the untreated conditioned medium (⁎⁎⁎pb0.001). (B)
Phosphorylation of p42/p44 MAP kinase in SPIβ cells upon incubation with
CM fromwtNIH3T3, SPIβ and SPIβS262Awith or without heat denaturation of
the CM. Cells were grown to 90% confluency and incubated for 10 min at 37 °C
with CM from wtNIH3T3, SPIβ or SPIβS262A cells, either heat denatured or
not. Equal amounts of cell lysate protein (25 μg) from NIH3T3, SPIβ and
SPIβS262A cells were subjected to SDS PAGE followed by Western blot
analysis using a p42/p44 MAP kinase specific antibody. Representative
experiment performed in triplicate. p-values were calculated relative to the
p42/p44 MAPK-immunobands obtained from the SPIβ incubated with the
untreated conditioned medium (⁎pb .05; ⁎⁎pb0.01; ⁎⁎⁎pb0.001).
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The anti-apoptotic activity of CM from wtNIH3T3 and
SPIα cells is caused by the presence of eicosanoids, the
synthesis of which is (partially) dependent on COX-2 activity
[13]. As shown by Western blot analysis, the level of COX-2
in SPIβ cells is reduced when compared to wtNIH3T3 cells
(Fig. 3A; lanes 1 and 4). Again the SPIβS262A cells
resembled the wild type cells as the levels of COX-2 were
comparable in both cell lines (Fig. 3A; lanes 1 and 7).
Arachidonic acid metabolites produced by COX-2 can
stimulate the expression of this enzyme via an autocrine
pathway [28,29]. By using an ELISA kit we showed that the
amount of PGE2 secreted by the SPIβ cells (0.16 ng/ml) is
similar to that of wtNIH3T3 cells (0.1 ng/ml). Therefore the
reduced level of COX-2 in SPIβ cells is not linked to a
decreased level of PGE2. When SPIβ cells were incubated for
5 h with PGE2 in combination with PGF2α, COX-2 levels
remained the same (Fig. 3A; lanes 4 and 5), whereas the COX-
2 levels of wtNIH3T3 and SPIβS262A cells were increased
(Fig. 3A; lanes 2 and 8). This strongly suggests that the
upregulation of COX-2 by PGE2/PGF2α is inhibited in SPIβ
cells. On the other hand, incubation of SPIβ cells with CM
from wtNIH3T3 cells did increase the COX-2 levels (Fig. 3A;
cf. lanes 4 and 6). A similar upregulation of COX-2 was
observed for wtNIH3T3 cells (Fig. 3A; cf. lanes 1 and 3) and
SPIβS262A cells (Fig. 3A; cf. lanes 7 and 9). This suggests
that the upregulation of COX-2 in SPIβ cells by CM from
wtNIH3T3 cells may be linked to the increased survival upon
UV irradiation under the same conditions. Lack of COX-2
induction by PGE2 and PGF2α in SPIβ cells agrees with the
failure to protect these cells (Fig. 2B). In contrast to COX-2,
expression levels of COX-1 were similar in all three cell lines
and did not change upon incubation with PGs or CM from
wtNIH3T3 cells (data not shown).3.3. p42/p44-MAP kinase activation
Activation of p42/p44 MAP kinase is commonly observed
after hormone or polypeptide growth factor induced prolifera-
tion or cell survival [30–33]. Incubation of wtNIH3T3, SPIβ
and SPIβS262A cells with CM from wtNIH3T3 cells induced
a rapid activation of p42/p44 MAP kinase (Fig. 3B; cf. lanes 3,
6, 9). Upon incubation with PGE2 and PGF2α, p42/p44 MAP
kinase was activated in wtNIH3T3 and SPIβS262A cells but
not in SPIβ cells (Fig. 3B; cf. lanes 2, 5, 8). These data
Fig. 6. Effect of prostaglandins and conditioned medium on the survival of wtNIH3T3 and SPIβ cells. Prostaglandin E2 and prostaglandin F2α protect wtNIH3T3 and
SPIβS262A cells against UV-induced apoptosis but fail to do so with SPIβ cells. The anti-apoptotic activity present in CM from SPIβ cells is masked by the presence
of an antagonist, which is inactivated upon heat treatment. Heat treatment of CM from wtNIH3T3 and SPIβS262A cells has no effect on the anti-apoptotic activity.
This suggests that the expression and phosphorylation of PI-TPβ is responsible for the production of the antagonist.
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wtNIH3T3 and SPIβS262A cells against apoptosis but fail
to protect SPIβ cells, indicating that in SPIβ cells this signal
pathway for stimulation of proliferation and cell survival is
inhibited.
3.4. Secretion of an antagonist of anti-apoptotic activity
SPIα cells secrete a highly potent anti-apoptotic and
mitogenic factor(s) [12,13]. Although to a lesser extent,
wtNIH3T3 cells also produce bioactive factors. Indeed, when
prior to UV irradiation SPIβ cells were incubated with CM from
wtNIH3T3 cells instead of DBB, the extent of apoptosis was
decreased by 45% (Fig. 4). Incubation of SPIβ cells with CM
from SPIβ cells did not prevent apoptosis. However, upon heat
treatment (20 min at 80 °C) CM from SPIβ cells expressed an
anti-apoptotic activity comparable to that from wtNIH3T3 cells
(Fig. 4). As a control, heat treatment of CM from wtNIH3T3
and SPIβS262A cells had little effect on the anti-apoptotic
activity indicating that this activity was heat stable. This
strongly suggests that CM from SPIβ cells contains a heat-labile
factor (antagonist) that interferes with the anti-apoptotic activity
present. The addition of CM from SPIβ cells containing the
antagonist did not increase the rate of apoptosis in the wild type
cells and apoptosis resistant SPIα cells, which suggests that the
antagonist has no pro-apoptotic activity. CM from SPIβS262A
cells resembled that from wtNIH3T3 cells indicating that
phosphorylation of PI-TPβ is required for the production of the
antagonist.
In agreement with the observations for cell survival, CM from
SPIβ cells after heat-treatment (20min 80 °C) induced COX-2 inSPIβ cells (Fig. 5A; cf. lanes 2 and 6) to the same extent as CM
from wtNIH3T3 cells (Fig. 5A; cf. lanes 4 and 6) and
SPIβS262A cells (Fig. 5A; lanes 6 and 8) whereas the untreated
CM from SPIβ cells had no effect on COX-2 expression (Fig.
5A; lane 5). Similarly, the untreated CM from SPIβ has no effect
on the level of p42/p44 MAP kinase, whereas the heat-treated
CM from SPIβ cells is able to activate MAPK (Fig. 5B; cf. lanes
5 and 6). For comparison, the untreated CM fromwtNIH3T3 and
SPIβS262A cells are able to activate MAPK in SPIβ cells (Fig.
5B; cf. lanes 3, 4, 7 and 8), resulting in protection of these cells
against UV induced apoptosis (Fig. 4).
The effect of PGE2/PGF2α and conditioned media on the
survival of wtNIH3T3 and SPIβ cells are summarized in Fig. 6.
4. Discussion
Previously we have shown that a ten-fold increase of PI-TPβ
in wtNIH3T3 mouse fibroblast cells (SPIβ cells) significantly
increases the sensitivity towards apoptosis induced by UV-
radiation [15]. Here we show that SPIβ cells incubated with
TNFα and serum starvation are much more prone to apoptosis
indicating that the increased apoptotic response was not
restricted to UV irradiation. A role of PI-TPβ in cell survival
was also indicated by the finding that initially, using another
expression vector (pSG5) than the one currently used (pBK-
CMV) we failed to obtain stable SPIβ cell lines. Due to high
levels of PI-TPβ we routinely observed that these cells died
after 4–5 passages. Previously we have shown that PI-TPβ is
mainly associated with the Golgi system and that this asso-
ciation requires the PKC-dependent phosphorylation of Ser-262
as the mutant PI-TPβ(S262A) is present throughout the cell
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parable to that of PI-TPβ (9.0 and 10.6 ng per 100 μg cytosolic
protein, respectively) the ensuing SPIβS262A cells have a
sensitivity towards apoptosis comparable to that of wtNIH3T3
cells [15]. This strongly suggests that there is a relationship
between the phosphorylation of PI-TPβ and the sensitivity
towards apoptosis.
On the other hand, recent studies concluded that the Golgi
localization of PI-TPβ is not dependent on the phosphorylation
of Ser-262 [34,35]. We do not have an explanation for this
discrepancy. However, we do find that increased levels of PI-
TPβS262A have no effect on the apoptosis sensitivity and thus,
regardless of Golgi localization, it is clear that phosphorylation
of PI-TPβ is required to affect apoptosis.
Two important parameters linked to apoptosis are activation
of p42/p44 MAP kinase and expression of COX-2 [36–38]. In
general, inhibition of COX-2 expression enhances apoptosis and
more specifically reduces the incidence and progression of
tumors in animal models [39–42]. Phosphorylation of p42/p44
MAP kinase through the RasNRafNMAP kinase kinase (MKK)
cascade is associated with proliferation, protection against
apoptosis and angiogenesis [30–33]. Here we show that the
prostaglandins PGE2/PGF2α, although present in CM from SPIβ
cells, are unable to upregulate COX-2 in SPIβ cells, but are able
to do so in wtNIH3T3 and SPIβS262A cells, showing that the
pathway of upregulation is blocked in SPIβ cells (Fig. 3A). This
results in a lower basal level of COX-2 in SPIβ cells and
prevents prostaglandins (PGs) from protecting SPIβ cells
against apoptosis. In addition we show that these PGs cannot
activate p42/p44 MAP kinase in SPIβ cells whereas this
pathway is activated in wtNIH3T3 and SPIβS262A cells (Fig.
3B). These observations may explain why SPIβ cells are more
prone to apoptosis and why PGE2 and PGF2α are unable to
induce survival in SPIβ cells. CM from SPIβ cells appeared to
lack the survival activity present in the CM from NIH3T3 cell.
Interestingly, CM from SPIβ cells acquired survival activity
upon heating, indicating that the expression of PI-TPβ is
responsible for the production and secretion of a component that
interferes with the action of the intrinsic survival factors present.
Attempts to gain insight into the nature of the PI-TPβ-dependent
‘antagonist’ were inconclusive. Experiments using protein
synthesis inhibitors and analysis of [14C]serine-labeled SM
metabolites secreted by SPIβ cells revealed no significant
differences compared with control cells.
The relationship between SM metabolism and apoptosis has
been investigated extensively. B-cell receptor-triggered apopto-
sis is associated with an early rise of C16 ceramide leading to the
subsequent formation of long chain C24 ceramide via activation
of effector caspases [43]. Apoptotic stimuli including TNFα
[44], ionizing radiation [45] and B-cell receptor cross-linking
[43] can generate ceramide by the induction of SM hydrolysis
through the action of sphingomyelinases or the de novo pathway.
In contrast to SPIβS262A and wtNIH3T3 cells, SPIβ cells
maintain the total level of SM under conditions where SM is
degraded in the plasma membrane to ceramide by exogenous
sphingomyelinase [7,9]. Although the mechanism by which PI-
TPβ regulates the rapid conversion of ceramide to SM is notknown, the data again strongly suggest that PI-TPβ must be
phosphorylated at Ser-262 in order to maintain the cellular SM
levels. Although increased levels of PI-TPβ appear to be
required for SPIβ cells to rapidly convert ceramide to SM [7], we
found that steady-state levels of ceramide in SPIβ and
wtNIH3T3 cells are similar. However, we did observe that the
molecular species of the fatty acids of SM (Fig. 1B) and cera-
mide are different with SPIβ cells having relatively less short
chain (C16) and more long chain species (C24:1/0) compared
with wtNIH3T3 cells. To date it is not known whether the
sensitivity towards apoptosis of SPIβ cells is related to this shift
from short chain to long chain ceramide/SM. However, it could
be that the relative enrichment of long chain SM species in SPIβ
cells has an effect on the plasma membrane and, thereby, affect
the properties of membrane proteins [46].
We propose that as a consequence of an antagonist blocking
of the autocrine action of the survival factor present in CM from
SPIβ cells, the SPIβ cells are more sensitive towards induced
apoptosis (summarized in Fig. 6). In addition, the failure of
PGE2/PGF2α to both activate p42/p44 MAP kinase and to up-
regulate COX-2 levels may also explain why SPIβ cells are more
prone to apoptosis (summarized in Fig. 6). At this point our data
suggest that since an increased expression of PI-TPβ promotes
apoptosis, the deletion of PI-TPβ may have a prohibitive effect
on apoptosis. Since apoptosis is an essential event during early
embryonic development, the proposed role of PI-TPβ in
apoptosis may explain why the generation of a PI-TPβ knock-
out mouse has failed [6]. Understanding why and how ex-
pression of a single protein decreases the rate of proliferation as
well as survival of cells might be of interest for research on
methods to decrease the growth of rapidly proliferating tumor
cells that have gained resistance against induction of apoptosis.
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